| ||||||||||||||
|
|
|||||||||||||


*Department of Surgery, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii;
Department of Anesthesiology, University of California-Los Angeles School of Medicine, Los Angeles, California, and Department of Anesthesiology, Charles R. Drew University of Medicine and Science, Martin Luther King, Jr./Drew Medical Center, Los Angeles, California; and
Department of Clinical Studies, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania
Address correspondence and reprint requests to J. S. Jahr, MD, UCLA Anesthesiology, Box 951778, Los Angeles, CA 90095-1778. Address e-mail to jsjahr{at}mednet.ucla.edu
The accuracy of the HemoCue® Plasma/Low Hemoglobin System was validated in vitr. with low levels of hemoglobin-based oxygen carriers (HBOCs). Repeated measurements were performed on 50 samples of canine plasma, each mixed with three different HBOCs at varying small concentrations (a total of 150 samples), by using plasma samples without HBOCs as controls. Two technicians performed the measurements and randomly tested each sample 10 times. The results were analyzed for correlation, and analysis of variance was used to evaluate statistical significance, with a P value of
0.05 considered significant. Hemoglobin concentrations determined with the bedside photometer were not significantly different from known values of hemoglobin concentration in the samples. There was no significant difference between values obtained by two independent observers for the same samples. This was true for all three tested HBOCs and for all tested concentrations. The mean bias of the measurement expressed as a percentage of sample concentration was 0.1% for hemoglobin glutamer-200 (bovine), 0.58% for hemoglobin glutamer-250 (bovine), and 0.19% for hemoglobin-raffimer. The mean error was <8% for all three HBOCs. Both intraobserver and interobserver reliabilities were high and statistically significant. The HemoCue® Plasma/Low Hemoglobin System is a reliable instrument for detecting and measuring small concentrations of three different HBOCs in plasma.
IMPLICATIONS: This study evaluated a new bedside blood-measuring device for low levels and found that it rapidly measured low levels accurately for three blood substitutes.
This article has been cited by other articles:
![]() |
I. P. Torres Filho, B. D. Spiess, R. N. Pittman, R. W. Barbee, and K. R. Ward Experimental analysis of critical oxygen delivery Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1071 - H1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Varlet-Marie, M. Ashenden, F. Lasne, M.-T. Sicart, B. Marion, J. de Ceaurriz, and M. Audran Detection of Hemoglobin-Based Oxygen Carriers in Human Serum for Doping Analysis: Confirmation by Size-Exclusion HPLC Clin. Chem., April 1, 2004; 50(4): 723 - 731. [Abstract] [Full Text] [PDF] |
||||
|